| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.34 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |